Back
HFA Premium Access

Biohumoral and echocardiographic correlates of tafamidis treatment in transthyretin cardiac amyloidosis

Session: Novelties in amyloid cardiomyopathy
Topic: Clinical
Speaker: Doctor V. Castiglione (Pisa, IT) Doctor G. Vergaro (Pisa, IT)
Event: Heart Failure 2023

Congress Presentation

About the speakers

Doctor Vincenzo Castiglione

Sant'Anna School of Advanced Studies, Pisa (Italy)
1 presentation
0 follower

Doctor Giuseppe Vergaro

Sant'Anna School of Advanced Studies, Pisa (Italy)
7 presentations
0 follower

3 more presentations in this session

Use and safety of sodium-glucose cotransporter 2 inhibitors in a prospective cohort of patients with transthyretin amyloid cardiomyopathy.

Speaker: Doctor M. Maccallini (Milan, IT)

Access
Abstract
Slides
Video
Thumbnail

Phenotypic expression and outcomes of cardiomyopathy caused by titin truncating variants: translational insights

Speaker: Doctor M. Perotto (Trieste, IT)

Access
Abstract
Slides
Video
Thumbnail

Prognostic value of tricuspid annular plane systolic excursion/systolic pulmonary artery pressure (TAPSE/SPAP) ratio in amyloid cardiomyopathy

Speaker: Doctor M. Maccallini (Milan, IT)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Novelties in amyloid cardiomyopathy

Speakers: Doctor V. Castiglione, Doctor G. Vergaro, Doctor M. Maccallini, Doctor M. Perotto, Doctor M. Maccallini
Access
Video
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb